Navigation Links
Safety to the Power of Three: B. Braun Medical Inc. Announces Introcan Safety® 3 Closed IV Catheter
Date:10/19/2011

BETHLEHEM, Pa., Oct. 19, 2011 /PRNewswire/ -- Expanding its offering of passive safety devices to protect both clinicians and patients from needlestick injuries (NSIs), B. Braun Medical Inc. (B. Braun) recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance of the company's Introcan Safety® 3 Closed IV Catheter, the next generation of B. Braun's Introcan Safety® IV Catheter. B. Braun made the announcement during the Association for Vascular Access 2011 Annual Scientific Meeting in San Jose, Calif., in early October.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

"Recent research(1) confirms passive safety engineered devices are most effective for needlestick injury prevention," said Tom Sutton, Vice President, Vascular Access and IV Systems for B. Braun Medical Inc. "The Introcan Safety® 3 is designed to provide clinicians with not only an effective passive needlestick safety device, but also an added layer of safety and control with a bidirectional blood control valve to aid in the prevention of blood exposure each time the device is accessed."

The Introcan Safety® 3 features all elements of B. Braun's existing and proven Introcan Safety® IV Catheter. From insertion to advancing the catheter to needle removal, the Introcan Safety® 3 is designed to help protect clinicians and patients from NSIs as the device cannot be bypassed or activated inadvertently.

B. Braun's Introcan Safety® 3 will provide protection through:

  • Passive Safety Needle Shield to aid in the prevention of NSIs
  • Multiple Access Blood Control Valve to aid in the prevention of blood exposure
  • Integrated Stabilization Platform to improve cathet
    '/>"/>

SOURCE B. Braun Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. USC School of Pharmacy to Double Presence in Safety-net Clinics
2. Varian Medical Systems Publishes First Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
3. White House Drug Policy Director and Mothers Against Drunk Driving Unite to Combat Drugged Driving; Call on Parents to Act to Reduce Significant Public Safety Threat
4. FDA CONSUMER HEALTH INFORMATION - FDAs MedWatch Safety Alerts: September 2011
5. 1-800-GET-THIN - Lap-Band Safety and You
6. The Educational Review Systems First Annual Pediatric Medication Safety Summit
7. FDA CONSUMER HEALTH INFORMATION -- Foreign Exporters Study Food Safety Law
8. SurgiCount Medical Announces Agreement with 130+ Hospital Operator to Implement the Safety-Sponge® System
9. FDA Issues Safety Communication Regarding Increased Risk of Blood Clots with Certain Birth Control Pills
10. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
11. Clinical Data Demonstrates Long-Term Safety of Boston Scientifics Alair[TM]Bronchial Thermoplasty System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 The global ... 49.12 billion by 2020, growing at a CAGR of ... report by Grand View Research, Inc. Monitoring services is ... from 2014 to 2020.      (Logo: ... with rising incidences of chronic diseases such as cancer, ...
(Date:8/27/2015)...  A recent study by Feucht et al, ... Arthrosurface HemiCAP® Wave implant, which is based on ... implant for isolated patellofemoral disease. While both implant ... scores, none of the patients in the "inlay" ... of the patients in the "onlay" group, showed ...
(Date:8/27/2015)... 27, 2015 Biosimilars are not generics ... U.S. Food and Drug Administration (FDA) for recognizing ... its draft guidance issued today. The FDA,s draft ... distinguishable names, calling for biological products to bear ... This proposal reflects the agency,s thinking that "there ...
Breaking Medicine Technology:mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... -- At this very moment, FIRMOO is being heatedly discussed ... eyeglasses from FIRMOO are being delivered to various countries of ... so many eyeglasses wearers? In this brand new year of ... platforms, is giving away thousands of free eyeglasses every day ...
... 6, 2012 ViroPharma Incorporated (NASDAQ: ... HALO ) today announced the presentation of positive ... Cinryze® (C1 esterase inhibitor [human]) in combination with ... using Halozyme,s recombinant human hyaluronidase enzyme (rHuPH20), in ...
Cached Medicine Technology:Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 2Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 3ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 2ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 3ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 4ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 5ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 6ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 7ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 8
(Date:8/30/2015)... ... 30, 2015 , ... Natural Rest contains a unique mixture of vitamins and ... remedies, which help to improve mood disorders and anxiety. Like all other Creative Medical ... the field of regenerative medicine conducted by Dr. Amit Patel of the University of ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products International ( http://www.nutricompany.com ... Executive Assistant to CEO Mitch Gould for Nutritional Products International. Through all ... Kathleen graduated from Florida State University with a Bachelor of Science in ...
(Date:8/29/2015)... ... 2015 , ... On September 30, 2015, the Career and Transfer Center (CTC) ... Maricopa Community Colleges , will be hosting a Job Expo to provide a ... opportunities. , The Expo has expanded to much more than just a typical job ...
(Date:8/29/2015)... , ... August 29, 2015 , ... ... of two inventors from Miller Place, N.Y. "I specialize in manual therapy, and ... In addition, it can be used for additional muscle dysfunction throughout the body." ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., ... His mission is to increase acceptance of the chiropractic field in the military. All ... debilitate them. Although Chiropractic was made available to the VA program over a ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2
... respiratory problems, CDC report says , , WEDNESDAY, Oct. 22 (HealthDay ... has soared 18 percent in the last decade, with an ... the condition, a new federal report says. , In 2007, ... reported to have had a food or digestive allergy in ...
... $1.60 per share in the third quarter of 2008 -- Medical membership grew by 63,000 ... exceeded 35.3 million at September 30, 2008 -- Benefit expense ratio declined by ... ... increased ...
... 22 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: ... medical devices worldwide today announced that it will,report ... September 30,2008, after the U.S. market closes on ... conference call at 8:00 a.m. on November,11, 2008 ...
... cost-pressured, limited pipeline biotech and pharmaceutical companies, the market for ... 2012. , ... San Jose, Calif. ... challenges in the form of increasing competition in generic markets, ...
... mother and gluten-free cook/author Theresa Santandrea-Cull - is a collection of ... and wheat products. , ... (PRWEB) October 22, 2008 ... latest recipe book "No Wheat? No Way!" she included ...
... health, how to diagnose disease early and other tips to prolong dogs, lives ... ... cause of death in dogs, affecting more than 10 percent of all dogs ... to this issue - www.yourdogsheart.com - is designed to educate pet ...
Cached Medicine News:Health News:Food Allergies Up 18% Among U.S. Children 2Health News:WellPoint Reports Third Quarter 2008 Results 2Health News:WellPoint Reports Third Quarter 2008 Results 3Health News:WellPoint Reports Third Quarter 2008 Results 4Health News:WellPoint Reports Third Quarter 2008 Results 5Health News:WellPoint Reports Third Quarter 2008 Results 6Health News:WellPoint Reports Third Quarter 2008 Results 7Health News:WellPoint Reports Third Quarter 2008 Results 8Health News:WellPoint Reports Third Quarter 2008 Results 9Health News:WellPoint Reports Third Quarter 2008 Results 10Health News:WellPoint Reports Third Quarter 2008 Results 11Health News:WellPoint Reports Third Quarter 2008 Results 12Health News:WellPoint Reports Third Quarter 2008 Results 13Health News:WellPoint Reports Third Quarter 2008 Results 14Health News:WellPoint Reports Third Quarter 2008 Results 15Health News:WellPoint Reports Third Quarter 2008 Results 16Health News:WellPoint Reports Third Quarter 2008 Results 17Health News:WellPoint Reports Third Quarter 2008 Results 18Health News:WellPoint Reports Third Quarter 2008 Results 19Health News:WellPoint Reports Third Quarter 2008 Results 20Health News:WellPoint Reports Third Quarter 2008 Results 21Health News:WellPoint Reports Third Quarter 2008 Results 22Health News:WellPoint Reports Third Quarter 2008 Results 23Health News:WellPoint Reports Third Quarter 2008 Results 24Health News:WellPoint Reports Third Quarter 2008 Results 25Health News:Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008 2Health News:Global Pharmaceutical Contract Manufacturing Market to Reach Over $31 Billion by 2012 According to a New Report by Global Industry Analysts, Inc. 2Health News:Global Pharmaceutical Contract Manufacturing Market to Reach Over $31 Billion by 2012 According to a New Report by Global Industry Analysts, Inc. 3Health News:Now Available Online, Beneficial Recipe Book Offers Wheat-Free, Gluten-Free Options for Healthy Living 2Health News:New Web Site Devoted to Canine Heart Disease - A Leading Cause of Death in Dogs 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: